Cambrian BioPharma Inc
Known title: 10% OwnerCIK: 0001797409
Cambrian BioPharma Inc's purchase track record
How the stock did after each of Cambrian BioPharma Inc's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
8
of 8 since December 16, 2021
Stock higher 6 months later
0%
3 months: 0%
Median 6-month return
-57.7%
3 months: -61.4%
Beat the S&P 500
0%
median -46.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/23/2022 | FTH | $86K | -57.0% | -48.8% | -2.0% |
| 2/11/2022 | FTH | $188K | -65.3% | -48.5% | -3.1% |
| 2/3/2022 | FTH | $159K | -64.4% | -56.0% | -7.3% |
| 1/26/2022 | FTH | $202K | -62.1% | -55.6% | -7.5% |
| 1/18/2022 | FTH | $531K | -62.5% | -61.4% | -14.0% |
| 1/10/2022 | FTH | $290K | -60.8% | -59.7% | -17.5% |
| 12/27/2021 | FTH | $428K | -58.4% | -59.3% | -18.6% |
| 12/16/2021 | FTH | $116K | -50.1% | -65.2% | -21.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| FTH | ▼ Sell | Open Market | 24,524 | $490K | 6/1/2026 | View on chart |
| FTH | ▼ Sell | Open Market | 476 | $10K | 6/1/2026 | View on chart |
| FTH | ▼ Sell | Open Market | 2,666 | $21K | 12/9/2025 | View on chart |
| FTH | ▲ Buy | Option Exercise | 395 | $3K | 12/9/2025 | View on chart |
| FTH | ▼ Sell | Open Market | 3,105 | $27K | 12/9/2025 | View on chart |
| FTH | ▼ Sell | Open Market | 395 | $3K | 12/9/2025 | View on chart |
| FTH | ▼ Sell | Open Market | 446 | $4K | 12/9/2025 | View on chart |
| FTH | ▼ Sell | Open Market | 14,508 | $165K | 12/5/2025 | View on chart |
| FTH | ▼ Sell | Open Market | 1,745 | $21K | 12/5/2025 | View on chart |
| FTH | ▼ Sell | Open Market | 42 | $553 | 12/5/2025 | View on chart |
| FTH | ▼ Sell | Open Market | 5,000 | $45K | 12/4/2025 | View on chart |
| FTH | ▼ Sell | Other | 1,587,302 | $2.0M | 7/31/2023 | View on chart |
| FTH | ▲ Buy | Grant | 4,466 | $0 | 7/10/2023 | View on chart |
| FTH | ▲ Buy | Grant | 4,466 | $0 | 6/10/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 1,203 | $4K | 3/2/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 2,458 | $9K | 3/1/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 42 | $151 | 2/28/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 2,500 | $9K | 2/25/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 15,000 | $54K | 2/24/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 2,500 | $10K | 2/23/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 15,000 | $60K | 2/18/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 4,949 | $21K | 2/17/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 2,551 | $11K | 2/16/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 10,000 | $42K | 2/14/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 12,500 | $55K | 2/11/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 5,000 | $23K | 2/10/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 10,000 | $43K | 2/8/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 2,500 | $11K | 2/4/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 17,500 | $81K | 2/3/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 8,900 | $38K | 1/28/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 6,100 | $26K | 1/27/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 29,900 | $138K | 1/26/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 20,100 | $98K | 1/25/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 22,707 | $106K | 1/24/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 24,703 | $122K | 1/21/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 20,000 | $103K | 1/20/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 10,244 | $51K | 1/19/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 10,000 | $51K | 1/18/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 6,219 | $31K | 1/14/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 19,953 | $102K | 1/13/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 9,202 | $48K | 1/12/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 10,845 | $56K | 1/11/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 10,000 | $53K | 1/10/2022 | View on chart |
| FTH | ▲ Buy | Open Market | 1,127 | $5K | 12/30/2021 | View on chart |
| FTH | ▲ Buy | Open Market | 69,000 | $344K | 12/29/2021 | View on chart |
| FTH | ▲ Buy | Open Market | 11,288 | $60K | 12/28/2021 | View on chart |
| FTH | ▲ Buy | Open Market | 3,712 | $20K | 12/27/2021 | View on chart |
| FTH | ▲ Buy | Open Market | 11,000 | $58K | 12/23/2021 | View on chart |
| FTH | ▲ Buy | Open Market | 117 | $619 | 12/17/2021 | View on chart |
| FTH | ▲ Buy | Open Market | 10,925 | $57K | 12/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
William Blair Begins Coverage of Faeth Therapeutics (FTH)
William Blair has started coverage of Faeth Therapeutics and issued an Outperform rating. The move may increase analyst attention and could influence market perception. The stock is currently trading below its 52‑week low and has a low RSI, indicating it is in a downtrend.
William Blair Begins Coverage of Faeth Therapeutics (FTH). William Blair has started coverage of Faeth Therapeutics and issued an Outperform rating. The move may increase analyst attention and could influence market perception. The stock is currently trading below its 52‑week low and has a low RSI, indicating it is in a downtrend.